← Russell 3000 cross-section

THC TENET HEALTHCARE CORP

Trailing twelve months to 2026-06-30 · as filed 2026-07-29, not restated
Healthcare

Scale

Market cap
$21.7bn
Revenue TTM
$21.8bn
Net income TTM
$3.2bn
Free cash flow
$3.0bn
Composite score
83.9
Sector rank
#435

Valuation

P / E
6.8
EV / EBITDA
3.6
EV / sales
0.9
FCF yield
13.94%
Earnings yield vs 10-yr
9.90pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
14.6%
EBITDA margin
24.9%
ROE
68.1%
ROIC
182.4%
Revenue growth
5.4%

Insider activity, last 90 days

Net open-market
$-37.50m
Buyers
0
Sellers
8

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

The 5.3% increase in our Ambulatory Care segment’s total consolidated cases in the three months ended June 30, 2026, as compared to the same period in 2025, was primarily attributable to incremental case volume from our 2025 and 2026 acquisitions and de novo development, partially offset by a decrease in same-facility case volume and the impact of the closure and sale of certain facilities. The following table presents net operating revenues by segment on a continuing operations basis: Consolidated net operating revenues increased by $357 million, or 6.8%, in the three months ended June 30, 2026 compared to the same period in 2025. …TENET HEALTHCARE CORP, 10-Q, period ended 2026-06-30, filed 2026-07-29

Read the full passage →